The RE(ACT) Congress & IRDiRC Conference 2020 will take place in Berlin, Germany from 11 to 14 March 2020.
This joint event will continue the RE(ACT) Congress series (6th edition) and IRDiRC Conference series (4th edition). It aims to bring together scientific leaders and experts and young scientists from a variety of breakthrough scientific fields to present cutting-edge research, exchange ideas, and discuss policies related to rare diseases research. Patients and patient organizations, who are committed to research, will also be in attendance to share their experiences and perspectives.
The scientific programme has been inspired by IRDiRC principles and achievements and by the IRDiRC activities foreseen in 2020. It encompasses topics like diagnosis and artificial intelligence, molecular etiology, innovative clinical trials, patient engagement, and drugs for all.
The RE(ACT) Congress – International Congress of Research on Rare and Orphan Diseases – was initiated in 2012 by the BLACKSWAN Foundation to create a forum for and promote scientific cooperation and research on rare and orphan diseases. IRDiRC – launched in April 2011 at the initiative of the European Commission and the US National Institutes of Health – fosters international collaboration on rare disease research by bringing together researchers, funders and patient advocacy organizations that work collaboratively within a multinational consortium.
The joint edition of the 6th edition of the RE(ACT) Congress and the 4th IRDiRC Conference to be held in Berlin, Germany, from 11-14 March 2020 is being organised in collaboration with the European Joint Program Rare Diseases (EJP RD) and in partnership with Eurordis (European alliance of patient organizations) and RDI – Rare Diseases International (global alliance of people living with a rare disease).
To register, click here